Secondary gout

Description

Secondary gout refers to those cases that develop during the course of another disease, or as a consequence of treatment with drugs. Secondary gout is associated with increased purine biosynthesis de novo, increased nucleic acid turnover, or decreased renal clearance of uric acid.

Exclusions from above levels

5C55.Y – Hyperuricaemia without signs of inflammatory arthritis or tophaceous disease
01 – Certain infectious or parasitic diseases
05 – Endocrine, nutritional or metabolic diseases

Show allHide

18 – Complications of pregnancy, childbirth and the puerperium
19 – Certain conditions originating in the perinatal period
22 – Injury, poisoning or certain other consequences of external causes
DA0E.8 – Temporomandibular joint disorders

Child codes

FA25.10 – Lead-induced gout
FA25.11 – Drug-induced gout
FA25.12 – Gouty arthropathy due to enzyme defects or other inherited disorders
FA25.1Y – Other specified secondary gout
FA25.1Z – Secondary gout, unspecified

Sibling codes

FA25.0 – Primary gout
FA25.2 – Gout without specification whether primary or secondary

Foundation entity

Secondary gout – http://id.who.int/icd/entity/680965837

Allowed postcoordination axes

Part of: FA25: Gout › 15: Diseases of the musculoskeletal system or connective tissue